A TCGA study analysed the mutational landscape in GBM, identifying the three main genetic events: amplification and mutational activation of RTK genes, activation of the PI3K pathway, and inactivation of the p53 and retinoblastoma tumour suppressor pathways [19]. This evidence concerns the gene TP53 and glioblastoma.